7073 results for "canc*"

in 13.80 milliseconds.

• Single cell RNAseq of PBMC from bladder cancer patients

  Study EGAS00001004458

• Whole exome sequencing from small cell lung cancer patients

  Study EGAS00001005087

• Genomic landscape of DS-ALL

  Study EGAS00001006600

• DNA polymerase and mismatch repair deficient cancers exert distinct genome-wide microsatellite signatures 2

  Study EGAS00001004816

• Expression profiles and genetic makeup of metastases of a cancer of unknown primary.

  Study EGAS00001004059

• Degradation of Cyclin K/CDK12 is a druggable vulnerability of colorectal cancer (H012)

  Study EGAS00001004517

• Extreme intratumor heterogeneity and driver evolution in mismatch repair deficient gastro-esophageal cancer

  Study EGAS00001003434

• AGECAN - Interespecies conservation of brain specific DNA methylation in aging and cancer

  Study EGAS00001004851

• Multi Omics of glioma in the the Chinese Glioma Genome Atlas (CGGA) project

  Study EGAS00001004729

• Mixed Histology Lung Cancers Driven by Transcriptomic Features rather than Genomic Characteristics

  Study EGAS00001005140

• Enhanced detection of MRD with cfDNA Fragmentomics.

  Study EGAS00001007192

• Analysis of Multiparametric MR imaging and tumor tissue sampling to identify response and acquired resistance to HIF-2 inhibition in patients with advanced clear cell renal cell carcinoma enrolled in a phase 1, multiple-dose, dose-escalation trial of PT2385, a HIF-2alpha inhibitor

  Study EGAS00001003506

• Biological and Therapeutic Implications of a Unique Subtype of NPM1 Mutated AML

  Study EGAS00001004872

• Multi-Region WES of Metastatic Colorectal Cancer

  Study EGAS00001003573

• Primary breast tumor heterogeneity through therapy

  Study EGAS00001003168

• GCP study

  Study EGAS00001004959

• Measuring minimal residual disease in acute myeloid leukemia with MASQ

  Study EGAS00001003732

• Whole-genome and transcriptome sequencing of blastic plasmacytoid dendritic cell neoplasm

  Study EGAS00001003660

• ID1 in glioblastoma

  Study EGAS00001003711

• Polyomavirus-positive Merkel cell carcinoma derived from a trichoblastoma suggests an epithelial origin of Merkel cell carcinoma

  Study EGAS00001003784

• Fresh vs. frozen cell preparations of colorectal cancer single-cell RNA sequencing

  Study EGAS00001003769

• Targetable ERBB2 Mutations in Neurofibroma/Schwannoma Hybrid Nerve Sheath Tumors

  Study EGAS00001003776

• Single cell RNA sequencing of 33 primary colorectal cancer

  Study EGAS00001003779

• Molecular profiling reclassifies adult astroblastoma into known and clinically distinct tumor entities with frequent MAPK pathway alterations

  Study EGAS00001003798

• Single cell sequencing: Capturing the origin and dynamics of chromosomal copy-number heterogeneity

  Study EGAS00001003812

• Characterization of T cell tumor infiltration in brain metastases through the analysis of the cerebrospinal fluid

  Study EGAS00001004751

• Concurrent germline and somatic pathogenic BAP1 variants in a patient with metastatic bladder cancer

  Study EGAS00001004055

• Targeted next-generation sequencing of 13 chordoid gliomas of the third ventricle

  Study EGAS00001002733

• Whole exome sequencing of chemotherapy-resistant muscle-invasive urothelial bladder cancer

  Study EGAS00001004231

• Rucaparib in patients presenting a metastatic breast cancer with Homologous Recombination Deficiency, without germline BRCA1/2 mutation, pronostic value of high LOH genomic score and predictive value of HRDetect (WGS)

  Study EGAS00001004756

• JAK and STAT alterations in CD30 positive LPD

  Study EGAS00001004181

• Prostate Cancer mitochondrial DNA heteroplasmies and mitochondrial gene expression

  Study EGAS00001004186

• Association of DNA-methylation profiles with immune responses in breast cancer patients

  Study EGAS00001004211

• Genetics and transcriptomics of human acute erythroid leukemia

  Study EGAS00001004203

• Bone metastatic biopsies of breast cancer patients progressing on endocrine therapies.

  Study EGAS00001004268

• : Centromeric cohesion failure invokes a conserved choreography of chromosomal mis-segregations in pancreatic neuroendocrine tumours

  Study EGAS00001004239

• Genetic characterization of a Unique Neuroendocrine Transdifferentiation Prostate Circulating Tumor Cell - Derived eXplant (CDX) Model

  Study EGAS00001004272

• Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma.

  Study EGAS00001004320

• Activating AKT1 and PIK3CA mutations in metastatic castration-resistant prostate cancer

  Study EGAS00001004328

• single-cell RNA-Seq of colorectal cancer patient samples

  Study EGAS00001006665

• Detailed molecular and immune marker profiling of archival prostate cancer samples

  Study EGAS00001004396

• Accelerated single cell seeding in relapsed multiple myeloma

  Study EGAS00001004404

• STM4 - Mouliere et al, 2018. Enhanced detection of circulating tumor DNA by fragment size analysis

  Study EGAS00001004418

• Impact of genetic variants in clinical outcome of a cohort of patients with oropharyngeal squamous cell carcinoma

  Study EGAS00001004430

• Genomic characterization of retinoblastoma

  Study EGAS00001005248

• Colorectal cancer cells possess an equipotent capacity to enter a developmental pausing-like state to survive chemotherapy

  Study EGAS00001004773

• Molecular analysis of CRC in patients with Primary Sclerosing Cholangitis (PSC) and Inflammatory Bowel Disease (IBD)

  Study EGAS00001004497

• Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine

  Study EGAS00001004525

• Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard and high risk myeloma

  Study EGAS00001004558

• Selective Elimination of Immunosuppressive T cells in Patients with Multiple Myeloma

  Study EGAS00001004915